Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Fortress Biotech (FBIO) Tax Provisions (2017 - 2025)

Historic Tax Provisions for Fortress Biotech (FBIO) over the last 7 years, with Q3 2025 value amounting to $26000.0.

  • Fortress Biotech's Tax Provisions fell 7400.0% to $26000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $462000.0, marking a year-over-year decrease of 354.91%. This contributed to the annual value of $312000.0 for FY2024, which is 4011.52% down from last year.
  • Per Fortress Biotech's latest filing, its Tax Provisions stood at $26000.0 for Q3 2025, which was down 7400.0% from $336000.0 recorded in Q4 2024.
  • Over the past 5 years, Fortress Biotech's Tax Provisions peaked at $500000.0 during Q4 2021, and registered a low of $26000.0 during Q3 2025.
  • In the last 5 years, Fortress Biotech's Tax Provisions had a median value of $336000.0 in 2024 and averaged $275857.1.
  • Per our database at Business Quant, Fortress Biotech's Tax Provisions crashed by 1020.0% in 2022 and then crashed by 7400.0% in 2025.
  • Over the past 5 years, Fortress Biotech's Tax Provisions (Quarter) stood at $500000.0 in 2021, then fell by 10.2% to $449000.0 in 2022, then dropped by 15.59% to $379000.0 in 2023, then decreased by 11.35% to $336000.0 in 2024, then plummeted by 92.26% to $26000.0 in 2025.
  • Its last three reported values are $26000.0 in Q3 2025, $336000.0 for Q4 2024, and $100000.0 during Q3 2024.